ADCT
Price
$4.23
Change
+$0.05 (+1.20%)
Updated
Dec 12 closing price
Capitalization
524M
87 days until earnings call
Intraday BUY SELL Signals
AXON
Price
$564.28
Change
-$16.75 (-2.88%)
Updated
Dec 12 closing price
Capitalization
44.53B
78 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs AXON

Header iconADCT vs AXON Comparison
Open Charts ADCT vs AXONBanner chart's image
ADC Therapeutics SA
Price$4.23
Change+$0.05 (+1.20%)
Volume$1.67M
Capitalization524M
Axon Enterprise
Price$564.28
Change-$16.75 (-2.88%)
Volume$943.93K
Capitalization44.53B
ADCT vs AXON Comparison Chart in %
View a ticker or compare two or three
VS
ADCT vs. AXON commentary
Dec 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a StrongBuy and AXON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 15, 2025
Stock price -- (ADCT: $4.18 vs. AXON: $581.03)
Brand notoriety: ADCT and AXON are both not notable
ADCT represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ADCT: 93% vs. AXON: 89%
Market capitalization -- ADCT: $524M vs. AXON: $44.53B
ADCT [@Biotechnology] is valued at $524M. AXON’s [@Aerospace & Defense] market capitalization is $44.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $316.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Aerospace & Defense] industry is $22.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileAXON’s FA Score has 1 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • AXON’s FA Score: 1 green, 4 red.
According to our system of comparison, AXON is a better buy in the long-term than ADCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while AXON’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 5 bearish.
  • AXON’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than AXON.

Price Growth

ADCT (@Biotechnology) experienced а +18.08% price change this week, while AXON (@Aerospace & Defense) price change was +5.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +3.23%. For the same industry, the average monthly price growth was +6.11%, and the average quarterly price growth was +19.07%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

AXON is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (+3.23% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($44.5B) has a higher market cap than ADCT($524M). ADCT YTD gains are higher at: 110.050 vs. AXON (-2.236). AXON has higher annual earnings (EBITDA): 311M vs. ADCT (-112.75M). AXON has more cash in the bank: 2.45B vs. ADCT (235M). ADCT has less debt than AXON: ADCT (117M) vs AXON (2.1B). AXON has higher revenues than ADCT: AXON (2.56B) vs ADCT (75.2M).
ADCTAXONADCT / AXON
Capitalization524M44.5B1%
EBITDA-112.75M311M-36%
Gain YTD110.050-2.236-4,921%
P/E RatioN/A178.57-
Revenue75.2M2.56B3%
Total Cash235M2.45B10%
Total Debt117M2.1B6%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
33
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTAXON
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
66%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
71%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 25 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
60%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
AXON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMNX259.4310.99
+4.42%
Rydex Precious Metals A
SSCCX0.360.01
+2.86%
Saratoga Small Capitalization C
COSSX15.100.08
+0.53%
Columbia Overseas Value Inst2
PWGIX28.600.13
+0.46%
Impax US Sustainable Economy Instl
FITIX24.13N/A
N/A
Fidelity Advisor Mid Cap II M

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+4.24%
QTTB - ADCT
39%
Loosely correlated
-4.79%
RGNX - ADCT
38%
Loosely correlated
-1.61%
CLRB - ADCT
38%
Loosely correlated
-5.97%
IBRX - ADCT
36%
Loosely correlated
-4.78%
AXON - ADCT
36%
Loosely correlated
+2.22%
More

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+2.22%
TECH - AXON
61%
Loosely correlated
-0.94%
VCYT - AXON
58%
Loosely correlated
-2.56%
BEAM - AXON
57%
Loosely correlated
+0.40%
SEER - AXON
56%
Loosely correlated
-1.09%
ADPT - AXON
56%
Loosely correlated
-2.03%
More